Tatipalli, M.; Siripuram, V.K.; Long, T.; Shuster, D.; Bernstein, G.; Martineau, P.; Cook, K.A.; Cristofoletti, R.; Schmidt, S.; Vozmediano, V.
Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation. Pharmaceutics 2021, 13, 849.
https://doi.org/10.3390/pharmaceutics13060849
AMA Style
Tatipalli M, Siripuram VK, Long T, Shuster D, Bernstein G, Martineau P, Cook KA, Cristofoletti R, Schmidt S, Vozmediano V.
Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation. Pharmaceutics. 2021; 13(6):849.
https://doi.org/10.3390/pharmaceutics13060849
Chicago/Turabian Style
Tatipalli, Manasa, Vijay Kumar Siripuram, Tao Long, Diana Shuster, Galina Bernstein, Pierre Martineau, Kim A. Cook, Rodrigo Cristofoletti, Stephan Schmidt, and Valvanera Vozmediano.
2021. "Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation" Pharmaceutics 13, no. 6: 849.
https://doi.org/10.3390/pharmaceutics13060849
APA Style
Tatipalli, M., Siripuram, V. K., Long, T., Shuster, D., Bernstein, G., Martineau, P., Cook, K. A., Cristofoletti, R., Schmidt, S., & Vozmediano, V.
(2021). Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation. Pharmaceutics, 13(6), 849.
https://doi.org/10.3390/pharmaceutics13060849